Skip to main content

Clinical Trials Using Docetaxel

Review the clinical trials studying docetaxel on this list and use the filters to refine the results by age and location. Some clinical trials are held at NCI-Designated Cancer Centers and may be supported by other organizations.

You can find more information about the types and phases of clinical trials and what to expect or use our Steps to Find a Clinical Trial.

Trials 51-75 of 108

Pembrolizumab and Chemotherapy before Surgery followed by Pembrolizumab after Surgery for the Treatment of Resectable Locoregionally Recurrent Head and Neck Squamous Cell Carcinoma
Status: Active
Location: 2 locations
Toripalimab, Carboplatin and Docetaxel for the Treatment of Stage III-IVB Sinonasal Cancer before Surgery
Status: Active
Location: 2 locations
A Study of Novel Agents or Combinations as Perioperative Treatment in Participants With Locally Advanced Resectable Gastroesophageal Adenocarcinoma
Status: Active
Location: 2 locations
Clinical Trial Evaluating the Safety, Tolerability and Preliminary Efficacy of BNT116 Alone and in Combinations in Patients With Advanced Non-small Cell Lung Cancer
Status: Active
Location: 4 locations
Implantable Microdevice for Evaluating Drug Responses in Patients with Head and Neck Cancers, the Window of Opportunity Study
Status: Active
Location: 2 locations
Trial of Therapeutic Cancer Vaccine OSE2101 in Patients With Non-Small Cell Lung Cancer and Secondary Resistance to Immune Checkpoint Inhibitor
Status: Active
Location: MedStar Georgetown University Hospital, Washington, District of Columbia
A Study Comparing Standard Treatments in People With Non-muscle Invasive Bladder Cancer (NMIBC), COMPARE IT Trial
Status: Active
Location: Memorial Sloan Kettering Cancer Center, New York, New York
Intravesical Gemcitabine and Docetaxel for the Treatment of Low Grade Intermediate Risk Bladder Cancer
Status: Active
Location: UF Health Cancer Institute - Gainesville, Gainesville, Florida
Phase II Trial of Neoadjuvant Chemotherapy (NAC) Alone or in Combination With Immunotherapy Vaccine PRGN-2009 in Subjects With Newly Diagnosed HPV-Associated Oropharyngeal (Head and Neck) Cancer
Status: Active
Location: National Institutes of Health Clinical Center, Bethesda, Maryland
Substudy 01I: A Study of Investigational Agents in Participants With Previously Treated Stage IV Squamous Non-small Cell Lung Cancer (NSCLC) (MK-3475-01I/KEYMAKER-U01I)
Status: Active
Location: University of Kentucky/Markey Cancer Center, Lexington, Kentucky
A Study of Investigational Agents in Participants With Previously Treated Stage IV Nonsquamous Non-small Cell Lung Cancer (NSCLC) (MK-3475-01H/KEYMAKER-U01)
Status: Active
Location: University of Kentucky/Markey Cancer Center, Lexington, Kentucky
Immunotherapy (Pembrolizumab) with Chemotherapy and Chemoradiation for the Treatment of Stage II-IVb Squamous Cell Cancer of the Nasal Cavity and Paranasal Sinuses, the I-NAPA Study
Status: Active
Location: M D Anderson Cancer Center, Houston, Texas
Intravesical Gemcitabine and Docetaxel for the Treatment of Non-muscle Invasive Bladder Cancer
Status: Active
Location: Banner University Medical Center - Tucson, Tucson, Arizona
Concurrent WOKVAC Vaccination, Chemotherapy, and HER2-Targeted Monoclonal Antibody Therapy before Surgery for the Treatment of Patients with Breast Cancer
Status: Active
Location: Fred Hutch/University of Washington/Seattle Children's Cancer Consortium, Seattle, Washington
Tadalafil in Combination with FLOT Chemotherapy prior to Surgery for the Treatment of Stage I-III Resectable Gastric/Gastroesophageal Junction Cancer
Status: Active
Location: Banner University Medical Center - Tucson, Tucson, Arizona
Trastuzumab, Pertuzumab and Docetaxel With or Without Carboplatin for the Treatment of Stage II-III HER2 Positive Breast Cancer, NeoTHERa Trial
Status: Active
Location: University of Kansas Cancer Center, Kansas City, Kansas
Evaluation of Immune Cells and Response-Adapted Chemoimmunotherapy before Surgery for the Treatment of Triple-Negative Breast Cancer, The NeoTRACT Trial
Status: Active
Location: University of Kansas Hospital-Westwood Cancer Center, Westwood, Kansas
A Study to Evaluate the Safety and Pharmacokinetics of Eflapegrastim in Pediatric Participants With Solid Tumors or Lymphomas and Treated With Myelosuppressive Chemotherapy
Status: Active
Location: Case Comprehensive Cancer Center, Cleveland, Ohio
Chemotherapy and Cemiplimab with or without Alirocumab before Surgery for the Treatment of Lung Cancer in Patients with Stage IB-IIIA Non-small Cell Lung Cancer
Status: Active
Location: Duke University Medical Center, Durham, North Carolina
Circulating Tumor DNA Monitoring for Treatment Response Prediction and Treatment Reduction after Surgery in Patients with Stage IB, II, and IIIB Non-small Cell Lung Cancer, DNA-PREDICT Trial
Status: Active
Location: University of Miami Miller School of Medicine-Sylvester Cancer Center, Miami, Florida
Chemotherapy with or without Radiation or Surgery in Treating Participants with Oligometastatic Esophageal or Gastric Cancer
Status: Active
Location: M D Anderson Cancer Center, Houston, Texas
Preoperative Hypofractionated Radiotherapy with FOLFOX for the Treatment of Stage I-III Esophageal or Gastroesophageal Junction Adenocarcinoma
Status: Active
Location: 2 locations
A Sequential Treatment Plan for the Treatment of Hormone Positive Metastatic Breast Cancer
Status: Active
Location: Moffitt Cancer Center, Tampa, Florida
Radiation Therapy with Cisplatin or Docetaxel and Cetuximab in Treating Patients with Stage III-IVB Head and Neck Cancer
Status: Active
Location: University of Pittsburgh Cancer Institute (UPCI), Pittsburgh, Pennsylvania
Epidiferphane and Taxane Chemotherapy for the Treatment of Breast Cancer
Status: Active
Location: UF Health Cancer Institute - Gainesville, Gainesville, Florida